Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Trandolapril.

Client Email

Product

Trandolapril
Trandolapril Mixture With Verapamil
HEALTH CANADA PATENTS

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Trandolapril

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 8 USDMF, 6 CEP/COS, 3 JDMF, 3 EU WC, 4 NDC API, 6 Listed Suppliers, $ API Reference Price

15 API Suppliers
8 USDMF
6 CEP/COS
3 JDMF
3 EU WC
4 NDC API
6 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 33 FDA Orange Book, 8 Europe, 29 Canada, 24 Australia, 8 South Africa, 4 Listed Dossiers

106 FDF Dossiers
33 FDA Orange Book
8 Europe
29 Canada
24 Australia
8 South Africa
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 6 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 33 Direct Compression, 29 Controlled & Modified Release, 24 Disintegrants & Superdisintegrants, 20 Lubricants & Glidants, 20 Granulation, 20 Thickeners and Stabilizers, 18 Co-Processed Excipients, 13 Solubilizers, 9 Film Formers & Plasticizers, 8 Chewable & Orodispersible Aids, 8 Topical, 7 Taste Masking, 6 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Emulsifying Agents, 4 Rheology Modifiers, 1 Surfactant & Foaming Agents

73 Fillers, Diluents & Binders
47 Coating Systems & Additives
33 Direct Compression
29 Controlled & Modified Release
24 Disintegrants & Superdisintegrants
20 Lubricants & Glidants
20 Granulation
20 Thickeners and Stabilizers
18 Co-Processed Excipients
13 Solubilizers
9 Film Formers & Plasticizers
8 Chewable & Orodispersible Aids
8 Topical
7 Taste Masking
6 Parenteral
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Emulsifying Agents
4 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 17 Finished Drug Prices

1 US Medicaid Prescriptions
17 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 6 Others

3 EDQM
2 USP
6 Others

$ API Ref.Price (USD/KG) : 4,912 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 3Abbott Laboratories Limited

02 1BGP Pharma Inc.

03 3BGP Pharma ULC

filter Patent Reset all filters

7 All

01 41341206

02 31341296

filter Product Reset all filters

7 All

01 7Trandolapril

filter Dosage Reset all filters

7 All

01 7Capsule

filter Exp Date Reset all filters

7 All

01 42018-03-20

02 32018-09-25

Product Main Page

01

Abbott Laboratories Limited

Trandolapril

AAPS 2024

Not Confirmed

Abbott Laboratories Limited

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 1 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Abbott Laboratories Limited

Trandolapril

AAPS 2024

Not Confirmed

Abbott Laboratories Limited

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 2 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Abbott Laboratories Limited

Trandolapril

AAPS 2024

Not Confirmed

Abbott Laboratories Limited

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 4 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BGP Pharma ULC

Trandolapril

AAPS 2024

Not Confirmed

BGP Pharma ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Trandolapril

Brand Name : MAVIK

Patent Number : 1341296

Filing Date : 1982-12-23

Strength per Unit : 0.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BGP Pharma Inc.

Trandolapril

AAPS 2024

Not Confirmed

BGP Pharma Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 0.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BGP Pharma ULC

Trandolapril

AAPS 2024

Not Confirmed

BGP Pharma ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Trandolapril

Brand Name : MAVIK

Patent Number : 1341296

Filing Date : 1982-12-23

Strength per Unit : 1 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

BGP Pharma ULC

Trandolapril

AAPS 2024

Not Confirmed

BGP Pharma ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Trandolapril

Brand Name : MAVIK

Patent Number : 1341296

Filing Date : 1982-12-23

Strength per Unit : 2 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?